In a peer review journal authored by Mikhail V. Blagosklonny, he explained more about rapamycin. The introduction of rapamycin was received with mixed reactions. Rapamycin is a maximal life-attaining drug that was discovered in Easter Island. Rapamycin is believed to improve the health conditions of living organisms and reduce the rate of aging. The drug is also thought to prolong life span. One of the many theories postulates that death in old mammals is caused by aging, a situation people refer to as death by natural causes.
Aging in living things should always be associated with aging of the cells. Hormones, such as insulin and testosterone, usually affect the mechanistic target of rapamycin (MTOR). Growth factors together with nutrients and oxygen affect MTOR pathway. MTOR stimulates the typical execution of cells. Rapamycin reduces cancer infection rate through prolonging life span.
The Effectiveness of Rapamycin
Mikhail explains how rapamycin also delayed the onset of old age related diseases. It reduced the growth of tumor in size and occurrence period. In an experiment performed with mice, it was discovered that mice treated with rapamycin survived longer than those not treated. It was also recorded that rapamycin treated mice had a higher weight, unlike the others in the control experiment.
The research paper authored by Mikhail argues that as old age creeps in, the body increases the functional rate, which later causes malfunctions and old age diseases. These old age diseases include hypertension and acceleration of osteoporosis. Aging is as result of continued organ development. Thus, rapamycin can alter these developments and delay old age.
About Mikhail Blagosklonny
Mikhail Blagosklonny is a distinguished professor of oncology at the famed Roswell Park Cancer Institute in New York. He advocates for rapamycin as a life longevity drug. He has established a respectable name in the scientific world due to his many published research papers. He is in charge of editing for leading journals like Aging, Cell Cycle, Oncotarget, and Cancer Biology & Therapy. His fields of specialization are in Anti-aging medicine and oncology. He is a former student of First Pavlov State Medical University. In this university, he acquired his M.D in internal medicine, carried out extensive research in experimental medicine and cardiology, and earned a Ph.D. for the same. Visit ResearchGate.Net to learn more about Mikhail’s latest work.